We are revolutionizing the world of targeted therapeutics.
We are developing targeted therapeutic products built on our active, energy-based targeting technology.
Our research has broad application in the treatment of inoperable solid tumors and in genomic medicine. Our lead program is a potential treatment for locally advanced nonresectable pancreatic cancer.
Our novel technology is a first-in-class, implantable platform that actively and precisely drives dugs into target organs using iontophoresis via non-circulatory pathways. Iontophoresis is the harnessing of mild electrical forces to transport molecules.
With experience in both pharma and medical devices, our team is uniquely positioned to develop novel targeted therapeutic products for the localized treatment of serious diseases.